PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Abroad (travel likely)RecruitingPHASE3

Conditions

Cryptogenic Ischemic Stroke · Patent Foramen Ovale

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Jean-Louis Mas, MD

    Principal Investigator

    GHU Psychiatrie et Neurosciences Paris

  • Gilles Chatellier, MD

    Study Director

    Hôpital Européen Georges-Pompidou